Week of 2026-06-16
Five trades surfaced this week from a single executive-branch official — Sara Bailey, Director of the Office of National Drug Control Policy — spanning metals, biotech, defense technology, and an energy-related position.
The Big Picture
This week's disclosures come entirely from one filer: Sara Bailey, the director of the Office of National Drug Control Policy (ONDCP). All five trades were disclosed on April 1, 2026, covering activity from late January through March. Each position falls within the $1,001–$15,000 disclosed range, and none of the trades carries a potential conflict-of-interest flag.
This Week's Notable Trades
Sara Bailey, Director (Office of National Drug Control Policy)
- Bought a $1,001–$15,000 position in GE Verona on March 1, 2026, disclosed April 1.
- Bought a $1,001–$15,000 position in Fidelity Advisor Biotechnology Fund Class C (FBTCX) on March 1, 2026, disclosed April 1. The fund holds shares in biotech and pharmaceutical companies.
- Bought a $1,001–$15,000 position in TMC The Metals Company Inc. (TMC) on February 1, 2026, disclosed April 1 — a 59-day gap between the trade and the disclosure date.
- Sold a $1,001–$15,000 position in TMC The Metals Company Inc. (TMC) on March 1, 2026, disclosed April 1. Bailey had purchased shares of TMC the prior month before closing out the position approximately four weeks later.
- Bought a $1,001–$15,000 position in Byrna Technologies Inc. (BYRN) on March 1, 2026, disclosed April 1. Byrna manufactures personal security devices and less-lethal weapons; it is classified in the Industrials sector.
By the Numbers
- Total trades disclosed this week: 5
- Buys: 4 | Sells: 1
- Most active official: Sara Bailey (5 trades)
- Most active agency: Office of National Drug Control Policy (5 trades)
- Top sector purchased: Industrials (1 trade — Byrna Technologies)
- Top ticker purchased: BYRN (1 trade)
- Potential conflicts of interest: 0
- Late filings this batch: 1 (Sara Bailey — TMC The Metals Company, see below)
Late to File
Under the STOCK Act, executive-branch officials must disclose trades within 45 days of the transaction date. One trade in this batch exceeded that window: Sara Bailey's purchase of TMC The Metals Company Inc. (TMC), transacted February 1, 2026, was not disclosed until April 1, 2026 — 59 days after the trade, or 14 days past the statutory deadline. No explanation was noted in the filing.
All-time: Across all executive-branch STOCK Act filings on record, 65.3% of disclosures — 6,515 of 9,971 — have been filed late. The officials with the most late filings on record are Donald J. Trump (1,040 late filings), Mitchell M. Zais (284), Nuria Fernandez (278), Gina M. Raimondo (206), and Eric S. Lander (203). Late filing is a disclosure-timing matter; it is not itself evidence of wrongdoing.
The Fine Print
Data derived from public STOCK Act disclosures. Disclosure date is not the trade date (filings lag 30-45 days). Dollar figures are disclosed ranges, not exact amounts. Conflict-of-interest flags are heuristic "potential overlaps," not assertions of wrongdoing. Not investment advice.